Enkosi ngokundwendwela indalo.com. Inguqulelo yebrawuza oyisebenzisayo inenkxaso encinci ye-CSS. Ngamava afanelekileyo, sicebisa ukuba usebenzise isikhangeli esihlaziyiweyo (okanye ukhubaze imowudi yokuhambelana kwi-Intanethi Explorer). Okwangoku, ukuqinisekisa inkxaso eqhubekayo, siya kubonelela ngendawo ngaphandle kwezitayile kunye neJavaScript.
I-peptides kwaye iproteni isetyenziselwa ukunyanga izifo ezahlukeneyo, kodwa zihlala zithatyathwe kwaye ifuthe labo lihleli nje. Ezi ntsimi zezakhiwo zemveli zinokupheliswa ngoncedo lobunjineli beemolekyuli, kodwa lo ngumsebenzi onzima. Iindlela zobunjineli zemolekyuli, ezisetyenziswayo kwi-insulin kwaye ngoku zisetyenziswa ngempumelelo kwii-bilibmarmicals ezininzi, zifuna ukukhutshwa kwe-peptides, iiprotein ezivela kwi-acidsty acid. Iimpawu ezithile kunye nendawo enamafutha aqhotyoshelweyo anokubonelela ngeendlela ezahlukeneyo ze-slongetions. Ukongeza, le teknoloji inokubonelela ngobomi obude obunesiqingatha emva koLawulo lweZiyobisi zePeptede, inokuguqula ukuhanjiswa kwe-peptides, kwaye inokubakho ukubakho kokujolisa kwi-tissue. Ngomsebenzi wokhuseleko lwe-Acids kunye neePropathi zeKhemikhali ezichazwe kakuhle, le teknoloji ibonelela ngendlela yokufunyanwa kwezichiza yeProteli.
Onke amaxabiso ngumnatha. I-VAT iya kongezwa kamva ekuphumeni. Ukubala irhafu kuyakwenziwa ekuphutsheni.
I-Mutshaler, M., inkosi, gf, i-Adams, DJ & Imeko ye-Alewood, i-PF Itrays kwi-Peptide School. I-Mutshaler, M., inkosi, gf, i-Adams, DJ & Imeko ye-Alewood, i-PF Itrays kwi-Peptide School.I-mutshaler, m., inkosi, gf, i-Adams, Dj no-Alevd, iimeko ze-PFE. I-mutshaler, m., inkosi, gf, i-Adams, DJ & Alewood, PF 多肽药物发现的趋势. I-mutshaler, m., inkosi, gf, i-Adams, DJ & Alewood, PFI-mutshaler, m., inkosi, gf, i-Adams, Dj no-Alevd, iimeko ze-PFE.Isizwe sokuvulwa komfundisi. 20, 309-325 (2021). Olu phononongo lujolise kwimicimbi yangoku neyakudala yokufunyanwa kweziyobisi.
UMüller, TD, Blür, M., Tschöp, Mh & dimarchi, rds, rd achastity ukufumanisa iziyobisi: inkqubela phambili kunye nemiceli mngeni kunye nemiceli mngeni. UMüller, TD, Blür, M., Tschöp, Mh & dimarchi, rds, rd achastity ukufumanisa iziyobisi: inkqubela phambili kunye nemiceli mngeni kunye nemiceli mngeni.UMüller, i-TD, iBrocker, M., i-Chop, MH kunye ne-DMamarker, i-Ddi-Gd Anti-Gartity yokufunyanwa kweziyobisi: Inkqubela phambili kunye nemiceli mngeni. Müller, TD, Blür, M., Tschöp, Mh & noDimarker, 抗肥胖药物发现抗肥胖药物发现: 进展和挑战. Müller, TD, Blür, M., Tschöp, Mh & Dimarke, rdUMüller, i-TD, iBrocker, M., i-Chop, MH kunye ne-DMamarker, i-Ddi-Gd Anti-Gartity yokufunyanwa kweziyobisi: Inkqubela phambili kunye nemiceli mngeni.Isizwe sokuvulwa komfundisi. 21, 20123 (2022). Olu hlaziyo lubonelela ngokuqonda kwiingxaki zokutyeba kakhulu, ngakumbi iingcebiso ezintsha ngokusekelwe kwi-peptides.
I-strohl, iproteni ye-WR Fusion yokwandisa isiqingatha sobomi bebhayoloji njengesona sicwangciso siphambili kwii-biogics. I-Biophapharmicocetuti 29, 215-239 (2015).
I-Evans, M. et al. Ukubambelela ngokulandela ngqo iziyobisi kunye nokujongana neziyobisi ze-antidiabet kunye nezonyango ngeziphumo ezinesigulana esineswekile 2 yeswekile: Uphengululo olucwangcisiweyo loncwadi. isifo seswekile. imetabolism. 24, 37790 (2022).
I-Polonsky, wh, zsher, L. I-Polonsky, wh, zsher, L.I-Polonsky Whi, umlobi l I-Polonsky, wh, zsher, L., Hessler, D., Brohn, D. kwaye ulunge kakhulu, JH 患者对每周一次的糖尿病药物的看法. I-Polonsky, wh, zsher, L., Hessler, D., Brohn, D. Kwaye kakhulu, JHI-Polonsky Whi, umlobi lisifo seswekile. imetabolism. 13, 144-149 (2011).
Hashimoto, M., Takada, K., Kiso, Y. & Muriko, S. Syntsisis ye-Insulin kunye nemisebenzi yazo yebhayoloji. Hashimoto, M., Takada, K., Kiso, Y. & Muriko, S. Syntsisis ye-Insulin kunye nemisebenzi yazo yebhayoloji.I-Hashimoto M., Takada K., Kiso y. kunye neMranishi S. Synthesis ye-Paltricis ye-Palminayl ye-insulin kunye nomsebenzi wazo webhayoloji. Hashimoto, M., Takada, K., Kiso, Y. & muranishi, S. 胰岛素棕榈酰衍生物的合成及其生物活性. I-Hashimoto, M., Takada, K., Kiso, Y. & MURAONIITI, S. SYNTETHISH NOSEBENZISI ZE-DELTINS ZE-MALMIVIVITIS.I-Hashimoto M., Takada K., Kiso y. kunye neMranishi S. Synthesis kunye ne-biologizy ye-Insulin Palrives.I-RESVIR 6, 171-176 (1989).
IKurtzhals, P. ET Al. I-albhamun i-Albumin ye-Fatid-Acid I-Inculin: Uhlobo lonxibelelwano lwe-ligand-protein kunye nokudibana phakathi kokubopha i-vivo. I-biochem. J. 312, 725-731 (1995). Lo msebenzi ngowokuqala ukubonisa ukwanda kobuhlobo-ubomi ngenxa yokubopha kwe-albhamun ukuya kwi-peptides ethathwe kwi-acidsty acid.
I-MJUK, T. & Waldmann, H. Synthesis yeProtesi eziLwimi. I-MJUK, T. & Waldmann, H. Synthesis yeProtesi eziLwimi.I-Myukh, t. neWadmann, H. Synthesis yeProtesi eziLwimi. I-MeJUK, T. & Waldmann, H. 脂化蛋白质的合成. I-MeJuch, t. & Waldmann, h.I-Myukh, t. neWadmann, H. Synthesis yeProtesi eziLwimi.I-bioconjogate. Imichiza. 27, 1771-1783 (2016).
I-Chen, B., ilanga, Y., Nniu, J., JK & WU, X. I-WU, X. I-Chen, B., ilanga, Y., Nniu, J., JK & WU, X. I-WU, X.I-Chen B., iLanga y., Niu J., Jarugumillill GK kunye ne-WU X. I-WU X. I-WU X. I-WU X. Iprotheyini. I-Chen, B., Ilanga, Y., Nniu, Jr., Gk & Wu, X. 功能: 功能, 功能. I-Chen, B., ilanga, Y., Nniu, J.I-Chen B., iLanga y., Niu J., Jarugumillill GK kunye ne-WU X. I-WU X. I-WU X. I-WU X. Iprotheyini.I-cytochemistry. I-Biology 25, 817-831 (2018).
UBrater, wf, uBhansali, SG & Morris, mna noMorris, siziindlela zoMdibaniso we-Biotherapeeutics UBrater, wf, uBhansali, SG & Morris, mna noMorris, siziindlela zoMdibaniso we-BiotherapeeuticsUBrater, VF, uBhansali, sg noMorris, iindlela zam ezimisela i-ageperapeic Agents emva kolawulo lwe-biotherapeloous. UBrater, WF, BHANANALI, SG & Morris, Mna SC 给药后生物治疗药物吸收的机制决定因素. UBrater, WF, BHANANALI, SG & MRIS, Mna SC I-CRATTER, WF, BHANANALI, SG & MRIS, MORIS, Mna SC Kwiiseka- сс UBrater, wf, uBhansi, SG & MRIS, MORIS, Mna se-MO SC Drication ShoungerI-AAPS J. 14, 559-570 (2012).
I-Gradel, AKJ et al. Izinto ezichaphazela i-insulin yokufunxa: Iimpembelelo zomahluko. J. Isifo seswekile. Ngo-2018, i-1205121 (2018).
IHildebrandt, P., uSejrsen, P., Nielsessen, Birch, K. IHildebrandt, P., uSejrsen, P., Nielsessen, Birch, K. I-Hildebrandt, P., USejrsen, P., Nielsesen, Birch, K. паце с с с с с с с с с пабтом. IHildebrandt, P., uSejrsen, P., Nielsessen, Birch, K. - L. Hildebrandt, P., P., Nielsesen, Birch, K. & Sesings, L. 扩散和聚合决定了糖尿病患者皮下组织对胰岛素的吸收. Hildebrandt, P., uSejrsen, P., Nielsesen, Birch, K. & Sesish, L. I-Hildebrandt, P., uSejrsen, P., Nielsesen, Birch, K. с сиабтомм. Hildebrandt, P., uSejrsen, P., Nielsesen, Birch, K. & Selch, L.Ukuskena. J. Klin. elebhu. tyala imali. 45, 685-690 (1985).
I-Mosekilde, E., Jensen, Ks, Binder, C., i-C I-Mosekilde, E., Jensen, Ks, Binder, C., i-CI-Mosekilde E, Jensen Ks, Binder S, Roming s, kunye ne-Thommminsson B. Ukulinganisa i-Remerption Kinetics ye-Inulin. I-Mosekilde, E., Jensen, Ks, Binder, C., I-P., I-PERMOM I-Mosekilde, E., Jensen, Ks, Binder, C., I-P.I-Mosekilde E, Jensen Ks, Bhinder S, Romming S, kunye ne-Thommming s, kunye ne-Thorteinsson B. Ukulinganisa i-Kineting Kinetics ze-Isulin eqhutywa nge-isulin.J. Pharmaconkinetics. I-Biopharmacy. 17, 67-87 (1989).
I-Kuna, m., Mahdi, F., Chade, I-AR & BIDWOL, GL III I-MODECOME SURMACOME SURMACOME SURMARYRICES, I-DEALINIRINIRINE YOKUGQIBELA I-BISTINE-Njenge-Polypeptide. I-Kuna, m., Mahdi, F., Chade, I-AR & BIDWOL, GL III I-MODECOME SURMACOME SURMACOME SURMARYRICES, I-DEALINIRINIRINE YOKUGQIBELA I-BISTINE-Njenge-Polypeptide. I-Kuna, M., Mahdi, F., Chade chade, GL III фченииетннннннннннннннннннннн соополидаставкарого эостастастастастасодоодоно. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Molecular size modulates pharmacokinetics, biodistribution, and renal deposition of biopolymeric elastin-like polypeptide for drug delivery. Kuna, M., Mahdi, F., Chade, AR & BIDDELE, GL III 分子大小调节药物递送生物聚合物弹性蛋白样多肽的药代动力学, 生物分布和肾脏沉积. I-Kuna, m., Mahdi, F., Chade, GL III MOLEKI LEALMER Iprojektha yePropathi ye-Polymer Polymer Iprojektha yePropathiI-Kuna, m., Mahdi, F., Chad, AR kunye ne-bidwell, GL III. I-pharmaconkinetics, i-phaidionistion kunye ne-Renan Reflor ye-Biopolymeric Elastin-njenge-polypeptivation ye-Polypeptivation yobukhulu bemolekyuli.Ingxelo yesayensi 8, 7923 (2018).
Harris, iJM, uMartin, ne & Momoni, M. Peberation: Inkqubo yeNovel yokuguqula i-farmacokinetics. Harris, iJM, uMartin, ne & Momoni, M. Peberation: Inkqubo yeNovel yokuguqula i-farmacokinetics. I-Harris, jm, martin, ne & modi, m. повинии процес процес процес процес процес процес процес процес процес процес процес процес процес процес процес процес Harris, iJM, uMartin, ne & Momoni, M. Peberation: Inkqubo yeNovel yokuguqula i-farmacokinetics. Harris, jm, martin, ne & modi, m. 聚乙二醇化: 一种改变药代动力学的新方法. Harris, jm, uMartin, ne & Momoni, M. 聚乙二感化: Indlela entsha yokutshintsha kwamayeza. IHarris, jm, uMartin, ne & Moda, M. повилилии кменеиюеики. IHarris, jm, uMartin, ne & Momoni, M. Peberation: Inkqubo intsha yokutshintsha i-pharmakinetics.ikliniki. I-pharmacokinetics. 40, 539-551 (2001).
Elserer, m. et al. Ukulinganiswa kwe-albhamulial albumin kwi-skeletal yemisipha yoluntu kunye nezicubu ze-tishu ngokuhamba ngokuvula okuvulekileyo. Ewe. J. I-Wuqulagy. I-Endocrine. imetabolism. 278, E352-E356 (2000).
Nelson, J. et al. Isiqingatha secala elide le-albhamun ebantwini ifuna i-C-pheptus. Nxibelelana. ibhayoloji. 3, 181 (2020).
I-cheddhhry, k. et al. I-FC Repptor (i-FCRN) ye-Igg enxulumene ne-fiysocompatimed enkulu ye-albhamun kwaye inyusa ubomi bayo. J. iyeza. 197, 315-32 (2003).
Ober, Rj, Martenz, C., X., X. Ober, Rj, Martenz, C., X., X. Orber, Rj, Martinez, C., Lai, X., Zhou, J. neWadi, ES э э азоз оровне олеку, Ober, Rj, Marclez, C., X., X. Ober, Rj, Martinez, C., Lai, X., Zhou, J. neWage, es 受体介导的 Igit Ober, Rj, Martinez, C., Lai, X., Zhou, J. newadi, es Orber, Rj, Martenz, C., X., X., Zhou, J. Ober, Rj, Martenez, C., I-LE, X.inkqubo. I-Avancy yesizwe yesayensi. isayensi. I-101, 11076 (2004).
Yena, xm & Carter, isakhiwo se-DC Atomic kunye ne-chemistry ye-ilbum ye-albumin yomntu. Yena, xm & Carter, isakhiwo se-DC Atomic kunye ne-chemistry ye-ilbum ye-albumin yomntu.I-XM kunye neCarter, isakhiwo se-DC Atomic kunye ne-chemistry ye-sybumin yomntu. Yena, xm & Carter, DC 人血清白蛋白的原子结构和化学. Yena, xm & Carter, DC.I-XM kunye neCarter, isakhiwo se-DC Atomic kunye ne-chemistry ye-sybumin yomntu.Indalo 358, 209-215 (1992).
I-curry, s., i-curkow, h., i-Brick, i-F. & F. & F. & Frans, N. Isakhiwo sekrim ye-ilbumin ye-albumin ye-Albumin Strongs enamafutha awobubi beendawo ezibophelelayo. I-curry, s., i-curkow, h., i-Brick, i-F. & F. & F. & Frans, N. Isakhiwo sekrim ye-ilbumin ye-albumin ye-Albumin Strongs enamafutha awobubi beendawo ezibophelelayo.I-curry s I-curry, s., i-Mandkok, H., Brick, P. & Frans, N. 与脂肪酸复合的人血清白蛋白的晶体结构揭示了结合位点的不对称分布. I-curry, s., i-curkow, h., i-Brick, i-F. & Frans, i-CryNks, N. I-CryStos, N. i-Crystal ye-Crystin ye-Acid ye-Acids ityhila ukuhanjiswa kwe-acids ezibophelelayo.I-curry sNat. Ulwakhiwo. I-Biology 5, 827-835 (1998). Eli phepha libonisa isiseko solwakhiwo lokubopha amanqatha aids ukuya kwi-serum albumin.
I-Irby, D., du, c. I-Irby, D., du, c.I-Irby, D., du, k. kunye ne-li, f. lipid-ichiza elinechiza lokuphucula ukuhanjiswa kweziyobisi. I-Irby, D., du, c I-Irby, D., du, cI-Irby, D., du, KI-Biochemistry 14, 1325-1338 (2017).
I-Torchilin vP yakutshanje kwicandelo le-liposomes njengabathwali iziyobisi. Isizwe sokuvulwa komfundisi. 4, 145-160 (2005).
Bhat, M., Jatyan, R. Bhat, M., Jatyan, R.Bhat, M., Jatyan, R. Bhat, M., Jatyan, R., Mittal, A., Mahato, Ri & Chitkara, D. 脂肪酸共轭疗法的机遇和挑战. Bhat, M., Jatyan, R., Mittal, Mahato, Ri & Chitkara, D. Fatty Acid Umngeni.I-Bhat M., Jatyan R.Imichiza. I-physics lipids 236, 105053 (2021).
USmith, R. & Taford, C. Hydrophobicty ye-chain chain n-alkyl carboxylic acids, njengoko kulinganiswe ngokusasazwa kwabo phakathi kwe-heptmane phakathi kwezisombululo zawo. USmith, R. & Taford, C. Hydrophobicty ye-chain chain n-alkyl carboxylic acids, njengoko kulinganiswe ngokusasazwa kwabo phakathi kwe-heptmane phakathi kwezisombululo zawo.USmith, R. ne-TANFOFO, K. HYDROPONIT YOKUGQIBELA I-AL-AlkylcyboxylboxYcyboxylicy i-acids ilinganiswe ngokusasazwa kwayo phakathi kwe-heptine kunye nezisombululo ze-HEPTE. USmith, R. & Taford, C. 长链正烷基羧酸的疏水性, 通过它们在庚烷和水溶液之间的分布来测量. USmith, R. & Taford, C. I-hydrophobility ye-长链正 alkylcarbarbarbarvesvents, ilinganiswe ngokusasazwa kwayo phakathi kwe-hydrogen peroxide kunye nesisombululo se-hydrogen peroxide nesisombululo se-hydrogen peroxide nesisombululo se-Hydrogen.USmith, R. ne-TANFOFO, K. HYDROPONIT YOKUGQIBELA I-AL-AlkylcyboxylboxYcyboxylicy i-acids ilinganiswe ngokusasazwa kwayo phakathi kwe-heptine kunye nezisombululo ze-HEPTE.inkqubo. I-Academy yeSizwe yeSayensi. ISAYENSI US 70, 289 (1973).
Liu, j. et al. Ukufunyanwa kweveki nje ye-Semaglutide Analog ye-glucagon-njengePeptide-1 (GLP-1). J. amayeza. Imichiza. 58, 7370-7380 (2015). Lo msebenzi ubonakalisa okokuqala ukuba kungenzeka ukuba kusetyenziswe kanye ngeveki enamafutha aftatity.
Østergaard, S. ET Al. Iziphumo zePyy3-36 dibasic Fatic Acid Acid kwi-Mini-pig Y2 Receptor kunye nesiqingatha sobomi. isayensi. Ingxelo 11, 21179 (2021). Eli nqaku libonisa ukubaluleka kwendawo ye-Acid ye-Acid, i-liker kunye nozinzo lwasemva kokuphuhliswa kwe-analog ye-PYY ye-PYY.
Ensenat-Vaser, R. ET AL. Ukungena kwe-Myristoylated Poptidedes kwi-membrane yeseli kujongwa ngokuthe ngqo kusetyenziswa i-facorescopy microscopy microscopy. I-54, 33-36 (2002).
UNelson, Ar, eBerland, l., noTobritton, NL & SERS, CERStoyl olwenziwe kwi-peptides kwiiseli eziphilayo. UNelson, Ar, eBerland, l., noTobritton, NL & SERS, CERStoyl olwenziwe kwi-peptides kwiiseli eziphilayo.I-NELSON AR, eBorland L, i-Allbritton NL. kwaye i-Sims se SEPIDE yezothutho kwiiseli zokuhlala zisekwe kwi-Myristoyl. UNelson, Ar, Borland, eBerland, l., noTobritton, NL & Sims, CE 基于肉豆蔻酰的肽转运到活细胞中. UNelson, Ar, Borland, eBerland, l., noTobritton, NL & Sims, CE.UNelson, Ar, Borland, L., Albritton, NL. kunye ne-Sims, ukuthutha kwi-Myristoyl-esekwe kwi-Myristyl-esekwe kwiiseli eziphilayo.I-biochemistry 46, 14771-16781 (2007).
I-Kabhanov, AV, ILevishav, AV & AlaKHOV, VY Lipid ukuqulunqwa kweeproteni kunye nezithuthi zazo. I-Kabhanov, AV, ILevishav, AV & AlaKHOV, VY Lipid ukuqulunqwa kweeproteni kunye nezithuthi zazo.Kabanov Av, iLevishav av, Alakilev v.yu. Utshintsho lwe-liipid lweeproteni kunye nezithuthi zazo ze-membrane. I-Kabhanov, AV, ILevishav, AV & ALAKHOV, VY 蛋白质的脂质修饰及其膜转运. IKabhanov, AV, ILevishav, AV & ALAKHOV, VYI-Kabhanov AV, iLevishav AV, Alakilev, ukuguqulwa kweLipid yeeproteni ze-VY kunye nezothutho zabo.Iprotein kubunjineli. I-Dese. 3, 39-42 (1989).
I-GAO, X., Mazière, i-AD, iindevu, r. & hannound, i-ronty, i-ronty, i-rn ene-cytololic ye-cystine-knot peptide. I-GAO, X., Mazière, i-AD, iindevu, r. & hannound, i-ronty, i-ronty, i-rn ene-cytololic ye-cystine-knot peptide.I-GAO, X., Mazier, i-AD, i-Byrd, R. kunye ne-ronnosh, i-ronnosh, i-ron facty acid, i-cytososh acid ye-Peptide ye-Peptide. I-GAO, X., Mazière, intengiso, iindevu, r. & hannoush, rn 脂肪酰化增强了胱氨酸结肽的细胞内化和胞质分布. I-GAO, X., Mazière, i-AD, iindevu, r., iKlumperman, J. & Hannoush, RN.I-GAO, X., Mazier, i-Ad, i-Byrd, R. kunye ne-hannoosh, i-ronnosh, i-ron i-scypoting yosulelo lwe-cysstine.U-Iscrounde 24, 103220 (2021).
Umbhaki, kwi-ET Al. Isiqingatha sobomi obuvela ebomini yi-YY3-36 isikhonkwane se-Reptide ye-Reptor Reffered. Moore. iyeza. 16, 3665677 (2019).
Mäde, v Mäde, vYenziwe, uBellmann-suckert, k., Kaser, A., i-mailer, i-G. kunye neBeck-Sicker, i-AGICKER, i-AIGKER, i-AIGKER, i-AIGKER, i-AGICKER, i-AICKICE ifuthe kakhulu kwi-Polyperic Polyperic Polyperic Polyperic Polyperic Polyperic Polyperical Polypetide. Mäde, v., Bellmann-Sickert, K., Kaiser, A. Mäde, v., Bellmann-suckert, K., Kaiser, A.Yenziwe, u-W., eBelmann-suckert, k., Kaiser, A., i-mailer, i-G. neBeck-Sicker, i-AGHEAR, i-AGICKER, i-AGICKER, i-AGCHEAR, i-AGCHEAG ifuthe kakhulu.Hedmedlelem 9, 2463-2474 (2014).
Aleksopoulou, F. Et Al. I-lipid metabolite prRp31 yi-Grpt ye-GPR10 kunye ne-NPFF2 Agonist eneziphumo ezinokubakho kwiziphumo. isayensi. Ingxelo 12, 1696 (2022). Olu phando lokufunda lubonisa umahluko phakathi kwe-mono- kunye ne-diacid esecaleni.
UPullsen, K. ET AL. Ukuphuhliswa kweziganeko zeAgonists eziZinzileyo ze-Y2 Repper Pyple pyy3-36. iyeza. Itanki yokugcina. 38, 1369-1385 (2021).
Ii-Quight-Slobolos, K. ET AL. Ukuchongwa kunye nokulinganiswa kwe-vitro kunye ne-vivo ye-vivo ye-vivo ye-HIXOOCHEAT kunye nokukhetha i-Glanocortin 4 Repptor (MC4-R) I-Alpptor (MC4-R) I-Alphane-I-Alphanoctu-Couting (i-alpha-Msh). J. amayeza. Imichiza. 55, 1969-1977 (2012).
I-Ramirez-Anderden, HS et al. Ukusebenza ixesha elide lokukhula kwe-hormone ye-hormone ebotshelelwe kwi-albhamun engapheliyo. I-bioconjogate. Imichiza. 29, 3129-314 (2018).
Madsen, k. et al. Ubudlelwane bemisebenzi kunye ne-Elongwation ye-GluCagon yeGlucagon-enjengePeptide-1 ye-Peptide-1: ukubaluleka kobude be-acid enamafutha, i-polay, kunye nevolumu. J. amayeza. Imichiza. 50, 6126-6132 (2007).
I-Wieczorek, B., petzle, jc, knuse, i-t. I-Wieczorek, B., petzle, jc, knuse, i-t. I-Wieczorek, B., petzle, jc, knuse, t., uLinderoth, L. ne-L. & SEFEART, J. I-Wieczorek, B., Spetzle, JC, KS., L., L. NE-L. NO-L. NO-L. NOKWENZA IXESHA LOKUGQIBELA LWE-GLP-1. I-Wieczorek, B., Spetzle, JC, KS., L. NE-L. NO-L. NO-L. NOKWENZA INDAWO YOKUGQIBELA, j. 衍生物 glp-1 衍生物. I-Wieczorek, B., Spetzle, JC, KS., L. NE-L. NO-L. NO-L. NOKWENZA INDAWO YOKUGQIBELA, j. 衍生物 glp-1 衍生物. I-Wieczorek, B., petzle, jc, knuse, t., linderoth, l. ne-L. & k. I-Wieczorek, B., Spetzle, jc, Krise, eLinderoth, L. & k. & k. & kofoed, J. Direclated Services of GLP-1.I-patent WO2012 / 140117 (2012).
Uselula, P.-lungu. Yima. I-Alogs enamandla, i-Glp-1 ye-GLP-1 ye-GLP-1 ye-Glp-1 eyenzelwe ukuhanjiswa okugqithileyo ngokusekwe kulwakhiwo oluncinci. inkqubo. I-Avancy yesizwe yesayensi. isayensi. I-143, 4140-4145 (2016).
I-Royalty, je, kooradsen, i-k. izifundo. I-Royalty, je, kooradsen, i-k. izifundo.I-Royalty, je, Kododsen, i-koodsen, e-Eskerod, o., i-Wolf, i-pharmacodines, i-pharmacodines, i-pharmacodinetics, i-pharmacodinetics, i-pharmacodines enesibindi kunye nezihloko ezityhafileyo.版税, Ge, Kododsen, G., Eskerod, O., i-WULFF, BUSHED, BS 单剂量和多剂量长效 α-Msh, 耐受性, 耐受性, 耐受性, 耐受性, 耐受性, 耐受性, 耐受性, 耐受性, 耐受性动力学和药效学研究科目.版税, je, Kododsen, i-G., Eskerod, O., i-WULFF, i-BS & Hansedage, i-BS TOAGOD kunye ne-MSHICOAG NOBUCHULE药效学研究科目.I-Royal, jee, iKododsen, i-G., Eskerod, o., i-Wolf, i-BSE, i-BOFOCKINE, i-pharm, i-pharm ye-Alten ye-Alpheeds kwimpilo esempilweni kunye nezihloko eziphezulu. I-Kinetics kunye ne-pharmacodynamics.UJC. ECIN. I-Pharmacodynamics. 54, 394-404 (2014).
I-Lau, J., F., K., L., L. I-Lau, J., F., K., L., L.I-LIU, J., F., K. I-LIU, J., F., K., Linderoth, L. & Th. Gergeren, H. ILau, J., F., K., Linderoth, L. & Th. Giggeren, H.I-Lau, J., Cruz, T., Linderoth, L. neTogersen, H. Aneucagon Agogues.I-Patent WORTEN WO2011 / 117416 A1 (2011).
Iwadi, bp et al. Ukuphakathi kwe-peptides uzinza uzinzo kwiziseko zokuphucula umsebenzi webhayoloji. Moore. imetabolism. 2, 468-479 (2013). Lo msebenzi ubonakalisa indima yamafutha acidi esecaleni kwe-acid ekuqinisekisweni kozinzo kunye nokubopha kweendawo ze-Peptiide.
Koskun T. et al. I-Ly3298176, i-novel dip gip kunye ne-glp-1 i-Glp-1 i-Glp-1 i-Glp-1 i-Glp-1 i-Glp-1 iAgonist yonyango lwe-Diebetes Moore. imetabolism. 18, 3-14 (2018). Eli phepha libonisa uyilo lwe-facked ye-Acid-1 / gip co-agonist yolawulo lweveki nganye ekliniki.
Kjedsen, i-TB et al. Ubunjineli bemolekyuli be-iCodin, i-analog yokuqala ye-Intanethi yakudala ebantwini. J. amayeza. Imichiza. 64, 8942-8950 (2021). Eli phepha libonisa ukuphuculwa kokuqala kwe-Fatid Acid efumana i-insulin yolawulo kube kanye.
UVan Wigteloostein, sb et al. I-Neoglyllinipids ye-peptides ende ende: i-aloides ye-guculan-efana ne-1 ye-peptde 1 enepropathi ye-albumin-e-Albumin-e-Albumin-Bing kunye ne-Vivo Petency. Moore. iyeza. 14, 193-205 (2017).
UZorzi, A., Merdendorp, SJ, uWinsi, K. ne-K. ne-Hitis, C. kunye ne-heinis, c. UZorzi, A., Merdendorp, SJ, uWinsi, K. ne-K. ne-Hitis, C. kunye ne-heinis, c.UZorzi, A., Merdendorp, SJ, uWilbbs, J., Dale, K. kunye neHaynes, i-haynes, kunye nokusetyenziswa kwayo njengeleyibhile ebonelela ngePeptide eseleyo. UZorzi, A., Merdendorp, SJ, uWilbbs, J., Deley, K. ne-K. ne-Heinis, C. 酰化七肽以高亲和力结合白蛋白. UZorzi, A., Merdendorp, SJ, uWilbs, J., Deley, K. ne-K. ne-K. ne-Heinis, 鎄化七.UZorzi, A., Merdendorp, SJ, uWilbs, J., Dale, K. kunye neHaynes, i-Haynes, S. Acty Heeple HeeperNat. Nxibelelana ne-8, 16092 (2017).